Voyager Therapeutics Inc VYGR Q1 2026 Earnings Narrowed Loss Meets Optimism in Gene Therapy Pipeline AYTU Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Stock Rises Slightly WIT Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Gain BRFH Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Rises on Progress AAP Q1 2026 Earnings EPS Surges Past Expectations Amid Challenging Retail Environment DHIL Q1 2025 Earnings EPS of 323 Reported Amidst Market Uncertainty